Chinese BCI startup StairMed closes $72.8M financing led by Alibaba
Shanghai-based StairMed closed RMB 500 million (~$72.8M) in a round led by Alibaba with participation from Tencent and other investors, bringing the company’s funding to over RMB 1.1 billion in the past year and targeting mid-2026 large-scale clinical development.
3 Apr 2026